trabajo final legislacion farmaceutica grupo 301504 2
Post on 01-Mar-2018
219 Views
Preview:
TRANSCRIPT
-
7/25/2019 Trabajo Final Legislacion Farmaceutica Grupo 301504 2
1/19
LEGISLACION FARMACEUTICA 1
MOMENTO FINAL EVALUACION POR PROYECTOS
301504_2
Tutor:
FREDDY ENRIUE !ARRETO
UNIVERSIDAD NACIONAL A!IERTA Y ADISTANCIA " UNAD
ESCUELA CIENCIAS DE LA SALUD# ECISALUD
TECNOLOGIA EN REGENCIA DE FARMACIA
MAYO " 201$
-
7/25/2019 Trabajo Final Legislacion Farmaceutica Grupo 301504 2
2/19
LEGISLACION FARMACEUTICA 2
CONTENIDOINTRODUCCION.............................................................................................................3
1. PLANTEAMIENTO DEL PROBLEMA DE INVESTIGACIN............................4
1.1 PLANTEAMIENTO DEL PROBLEMA...........................................................4
2.JUSTIFICACION.4-5
3. MARCO TEORICO....5
4. METODOLOGIA.7
4.1. ANLISIS DE LOS RESULTADOS.........................................................................7
AREAS !"#$%&'11 PERSONAL DOCUMENTACION NECESARIA S%"% $%()*#*"%&' DOTACION
E+UIPOS COSTOS V#"%*,& ,$ !,&%&' CRONOGRAMA DE IMPLEMENTACION
5. CONCLUSIONES...........................................................................................................
. RECOMENDACIONES.................................................................................................
7. REFERENCIAS..............................................................................................................
-
7/25/2019 Trabajo Final Legislacion Farmaceutica Grupo 301504 2
3/19
LEGISLACION FARMACEUTICA 3
INTRODUCCI%N
P%* (,/% , ,&0, 0*#)#% &, *,#"/#*# &, /(!",(,$0#*# $ &/&0,(# , ,&0/$ ,$ ,"
&,*6//% 8#*(#90/%: ,$ #$0% # "#& ,&0*#0,/#& )##& ,$ "# ,8//,$/#: #"/# ;
*,$0#)/"/# 9 ## &,*6//% ;# &,# , (,/#$# ; #"0# %(!",/#. C,*0/8/#$% ,"(!"/(/,$0% , "#& $%*(#0/6/#,& ",#",& 6/,$0,& ,$ )#&, #" *,"#(,$0% *,&%"/$
14
-
7/25/2019 Trabajo Final Legislacion Farmaceutica Grupo 301504 2
4/19
LEGISLACION FARMACEUTICA 4
?%&!/0#" R,/%$#" S#$ J,*$/(% , A;#!,"
1'1' PLANTEAMIENTO DEL PRO!LEMA
L%& 80*%& R,,$0,& , F#*(#/# #$ /$*,% # "#)%*#* ,$ "# IPS ," M$//!/% ,A;#!," C*%)# , 0,*,* ; #*0% $/6," , #0,$/$ ; %(!",/# ?%&!/0#"#*/# ""#(#%
@?%&!/0#" R,/%$#" S#$ J,*$/(% , A;#!,": ,$ %$, #; 8# , /$&(%&
=/**/%& ; (,/#(,$0%&: $# 8#0*#/$ /$#,## ; (#& $% %$8%*(/#,&
%$ "# !%"0/# , &,*/# ," !#/,$0, #,(>& , %0*%& /$%$6,$/,$0,& %(% ,$0*,#
/$%!%*0$# , (,/#(,$0%&: /$#,#% &/&0,(# , /$6,$0#*/%& ; 8#"0#$0,&: ,
/$#,#% &/&0,(# , 8#*(#%6//"#$/#.
E$ #$0% #" !*%,&% , #"(#,$#(/,$0% &, ,&0> 6/,$% #8,0#% !%*=, ,)/% #"
*,/(/,$0% ," ,&0#)",/(/,$0% # #)/% $,,&/# , )/#* "%& /$&(%& ,$ /8,*,$0,&
"#*,& ,$,*#$% !*%)",(#& , )/#/$ ; , (#"%& ,&!#%& ,$ ," (%(,$0% , "#
/&!,$/$ ;# &,# !%*=, &, ,$0*,# $ (,/#(,$0% !%* %0*% % !%*=, &, $/,#$ "%&
(,/#(,$0%&. P#*# ," !*%,/(/,$0% , *,,!/$ ," R,,$0, , F#*(#/# 0/,$,
#&/$#% #" #/"/#* , 8#*(#/# !,*% # ,$%$0*#% =, *#$0, ," "0/(% (,& ,"
#/"/#* $% # ,"#)%*#% ," #0# , *,,!/$: !%* "% =, &, 6/% ,$ "# $,,&/# ,
""#(#*", "# #0,$/$.
Adems con base a lo realizado en todo el desarrollo del curso implementar un
sistema de gestin en un servicio farmacutico o establecimiento farmacutico de
acuerdo a las reglamentaciones legales vigentes en un depto. De dicha
institucin.
2' &USTIFICACI%N
E" (/$/&0,*/% , P*%0,/$ S%/#" (,/#$0, "# R,&%"/$ N(,*% 14
-
7/25/2019 Trabajo Final Legislacion Farmaceutica Grupo 301504 2
5/19
LEGISLACION FARMACEUTICA 5
D, /#" 8%*(# (,/#$0, R,&%"/$ 4
-
7/25/2019 Trabajo Final Legislacion Farmaceutica Grupo 301504 2
6/19
LEGISLACION FARMACEUTICA 6
E" (9/% *,#"/#*# & 8*("# (9/# &/&0,(#0/## ," #" $%& !,*(/0, #
$%&%0*%& %(% *,,$0,& *,#"/#* ," *,&!,0/6% ,*, ; !%&0,*/%*(,$0, #,*
"# ,$0*,# , "%& (,/#(,$0%& ; /&!%&/0/6%& (9/%& &%"//0#%&. C#$% ," &,*6//% %&!/0#"#*/% =/,*#$ *,#"/#* $# ,6%"/$ ;# &,# !%*
#()/% , !*,&*/!/$ (9/# % !%* 8#"",/,$0, % !%* #"=/,* %0*% (%0/6% !%*
(,/% , ,&0, &/&0,(# &, #*> ,$0*## # "%& (,/#(,$0%& % /$&(%&
#$0,*/%*(,$0, &%"//0#%&. M,/#$0, ," &/&0,(# !%*,(%& 6,*/8/#* ; #* $ !*%(,/% , =,
(,/#(,$0%& ; /&!%&/0/6%& (9/%& ",$ (>& !#*# #& 0,$,* $ &0%K %(%
(/$/$% ; $% 0,$,* 8#"0#$0,& C%$ "# /(!",(,$0#/$ ," &/&0,(# ;# $% 0,$*#(%& ,$0*,#& /$%!%*0$#& ;#
=, (,/#$0, ," &/&0,(# &,*# (>& 8>/" 6,*/8/#* "#& ,/&0,$/#& ; #&
!%&0,*/%*(,$0, *,#"/#* !,/%& , (,/#(,$0%& % /$&(%& =, ,&09$ !%*
#%0#*&,. T#()/9$ &, !"#$0,#*# =, ## 0*,& (,&,& &, ## $ /$6,$0#*/% "% #*#(%&
#$% $ /$8%*(, , "% =, &, 0/,$, ,$ &/&0,(# ; ,$ 8&/% !#*# %$&0#0#*
#$0/#,& ; (/*#* =, ," &/&0,(# 0,$# $ ),$ 8$/%$#(/,$0%. L%& #6#$,& 0,$%"/%& #$ !,*(/0/% )* $,6#& #"0,*$#0/6#& !#*# ,"
(#$,% , "# /$8%*(#/$ &/&0,(#0/#%: E" &%80#*, ,& , *#$ 0/"/# !#*# ,"
,**%""% , "# /$&0/0/$ ;# =, 6# 0,$,* $ %$0*%" %$0/$% &%)*, "#/6/#,& %(,*/#",&: 8/$#$/,*#& ; #(/$/&0*#0/6#& !,*(/0/,$% $ (,%*
&,*6//% #" !#/,$0,. L# !*/$/!#" ,**#(/,$0# %$ =, %$0#*# ," R,,$0, , F#*(#/# ,& ," &/&0,(#
=, 8$/%$#*# , #,*% # "#& $,,&/#,& =, !%&,, "# IPS !#*# ," ),$
(#$,% , /$6,$0#*/%& , (,/#(,$0%& , /$&(%& (,/#$0, ," &% ,"
#!"/#0/6% &, "",6#*# $# /$0,*#/$ !,*(#$,$0, %$ ," >*,# 8/$#$/,*# "# #"
!,*(/0/*> #$#"/#* ; %$0*%"#* "#& #$0/#,& ,#0# , (,/#(,$0%& , /$&(%&
%$ "%& =, ,$0# "# IPS ,$ $ 0/,(!% ,0,*(/$#% ; # & 6, %$0*/);, #"
(,%*#(/,$0% ; /$#(/&(% , "# /$8%*(#/$ 8/$#$/,*#.4' M(to)o*o+,-
L# /(!",(,$0#/$ , $ S/&0,(# , %$0*%" , /$6,$0#*/%& ; ,/&0,$0,& ,$ /$&(%&
(,/% =/**/%& !#*# "# IPS ?%&!/0#" R,/%$#" S#$ G,*$/(% ," ($//!/% ,
A;#!," C*%)#: &, *,#"/# # !#*0/* , "# &//,$0, !*%!,&0#.
A./* )(* ro*(-'
-
7/25/2019 Trabajo Final Legislacion Farmaceutica Grupo 301504 2
7/19
LEGISLACION FARMACEUTICA 7
E$ "# IPS ?%&!/0#" R,/%$#" S#$ G,*$/(% !*,&,$0# "#& &//,$0,& 6#*/#)",&
!*%)",(#0/#%*#& # "#& #",& &, !*,0,$, #* &%"/$ (,/#$0, $ &/&0,(# , %$0*%"
, /$6,$0#*/%& %$ ," %),0/6% , (,%*#* ," &,*6//% 8#*(#90/% , #,*% # "% =,
,0,*(/$# ," M%,"% , G,&0/$ ," S,*6//% F#*(#90/% ; M#$#" , C%$//%$,&
E&,$/#",& ; P*%,/(/,$0%&: ,8/$/%& ,$ "# R,&%"/$ 14
-
7/25/2019 Trabajo Final Legislacion Farmaceutica Grupo 301504 2
8/19
LEGISLACION FARMACEUTICA 8
"#*#(,$0, "%& %),0/6%& ; !*%!&/0%& , #"/#. E&0# ,), (%&0*#* & !*%!&/0% ,
(#$,*# 6/&/)", ; #0/6# # "%& /$0,*#$0,& ," ,&0#)",/(/,$0%.
Or+-.-67.:L# IPS ?%&!/0#" R,/%$#" S#$ G,*$/(% ," ($//!/% , A;#!,"
*%)# ,), ,&0#)",,* ; (#$0,$,* $# #,## ,&0*0*# %*#$/#/%$#" =, !,*(/0##&,*#* =, ,&0%& &,#$ #"(#,$#%& ; /&0*/)/%& , #,*% %$ "#& %$//%$,&
,&0#)",/#& !%* "%& 8#)*/#$0,&.
T%%& "%& /$0,*#$0,& , "# %*#$/#/$ ,),$ %$%,* ," #"#$, ; *,&!%$)/"/# ,
&& 8$/%$,& ; & /(!#0% ,$ "# #"/# , "%& /&!%&/0/6%& (9/%& % &,*6//%&. L# IPS
?%&!/0#" R,/%$#" S#$ G,*$/(% ," ($//!/% , A;#!," *%)#: ,),$ %$%,* "%&
%),0/6%& , #"/# ; ,),$ #&(/* "# *,&!%$)/"/# !#*# "%*#*"%&. L#&
*,&!%$)/"/#,& ,*,$/#",& ; "#& ," !,*&%$#" /$6%"*#% ,),$ ,&0#* "#*#(,$0,
,8/$/#& ,$ ," (#$#" , 8$/%$,&. S, ,), ,#(/$#* "%& %$8"/0%& , /$0,*9& !#*#
#&,*#* =, "# ,8,0/6/# ," &/&0,(# , #"/# $% &, ,0,*/%*,. L# IPS ?%&!/0#"
R,/%$#" S#$ G,*$/(% ," ($//!/% , A;#!," *%)#: ,), #&,*#* =, ,$0# %$
"%& *,*&%& 8&/%&: 0,$%"/%& ; (#$%& $,,*/%& !#*# #*#$0/#* =, ,$ ,&0%& &,
(#$0/,$,$ "#& %$//%$,& , #"/# ,&0#)",/#& !%* ," 8#)*/#$0,.
PROCESO RECURSOS 8UMANOS RECURSOS TECNOL%GICOS
S(*(667. +(/% 8#*(#,0# %
0,$"%%,$ *,,$/#, 8#*(#/#
R,&%"/$ 14
-
7/25/2019 Trabajo Final Legislacion Farmaceutica Grupo 301504 2
9/19
LEGISLACION FARMACEUTICA 9
D,*,0% 22
-
7/25/2019 Trabajo Final Legislacion Farmaceutica Grupo 301504 2
10/19
LEGISLACION FARMACEUTICA 10
L- or+-.-67. )( *- /r(- )(.tro )(* -*-6.
P#*# "%*#* $ &,*6//% ,8//,$0,: $ #"(#9$ ,), %$0#* %$ "#& &//,$0,& >*,#&
*,# , *,,!/$ , (,/#(,$0%& ; /&!%&/0/6%& (9/%&. *,# , #*,$0,$# , (,/#(,$0%&. *,# #,## !#*# #"(#,$#(/,$0%: 0,$/,$% ,$ ,$0# "%& 0/!%& , !*%0%&
=, &, 6#$ # /&0*/)/* ;% /&!,$*. *,# /$,!,$/,$0, ; &,*# !#*# ," #"(#,$#(/,$0% , (,/#(,$0%& ,
%$0*%" ,&!,/#". *,# !#*# ," ,&!#% , (,/#(,$0%& ; /&!%&/0/6%& ; (9/%&. *,# ,)/#(,$0, /,$0/8/## !#*# ," #"(#,$#(/,$0% , (,/#(,$0%& =,
,),$ &,* ,&0*/%& % ,&$#0*#"/#%&: !%* 6,$/(/,$0% % ,0,*/%*%.
*,# ,&0/$## !#*# ," #"(#,$#(/,$0% , !*%0%& *,##%&: ,6,"0%& ;*,0/*#%& ," (,*#%.
*,# !#*# ," (#$,% ; /&!%&//$ , *,&/%&: , #,*% %$ "# *,"#(,$0#/$
6/,$0,.
A//%$#"(,$0,: &, ,), %$0#* %$ ,&!#/%& !#*# ," >*,# #(/$/&0*#0/6#: &,*6//%&
!)"/%&: 6,&0/*9: #)/$,0,& , /$,$/%& ; ,0/$/%*,& ; ,!,$/,$% , &&
%$//%$,& ,&!,/#",&: &/0/% !#*# (#0,*/#" , */,&% "=/%& /$8"#(#)",&: 0/%&:
%**%&/6%&: ,0.'
P#*# $# #,## &,#"/#/$ , "#& >*,#& ,&0>$ ,),$ &,* ,(#*##& %$ "%&
&//,$0,& %"%*,&.
;REA COLOR *,# , *,,!/$ V,*,*,# , *,6/&/$ R%%*,# , #"(#,$#(/,$0% A(#*/""%*,# , #*,$0,$# N%. 1 N#*#$#
*,# , #*,$0,$# N%. 2 N,*#*,# , (,/#(,$0%& , %$0*%" V/%",0#*,# , *,/"#, R%% R#;#%*,# , #,$# , 8*/% A"*,# , !*,!#*#%& (#/&0*#",& A" R#;#%
Po:D,),$ &,* /(!,*(,#)",&: &"/%&: *,&/&0,$0,&: #$0/,&"/#$0,&: , 8>/" "/(!/,# ;
$/8%*(,&: , (#$,*# =, %8*,#$ %$0/$/# !#*# ,6/0#* 0*%!/,%& ; #/,$0,&.
D,),$ &,* , (#0,*/#" =, $% 0*#&(/0# */% $/ 6/)*#/$.
-
7/25/2019 Trabajo Final Legislacion Farmaceutica Grupo 301504 2
11/19
LEGISLACION FARMACEUTICA 11
P-r()(: D,),$ &,* /(!,*(,#)",&: &"/#&: *,&/&0,$0,& # 8#0%*,& #()/,$0#",&: ,
&!,*8//, "/: , /$%()&0/)",&. L%& (#0,*/#",& =, &, &,$ ,$ & 0,*(/$#% $% ,),$
%$0,$,* &&0#$/#& 0/#&: /**/0#$0,& % /$8"#(#)",&.
T(6& , #(,$0#* "# 0,(!,*#0*# #()/,$0#":
/$,&0#)/"/# *#$ !#*0, , "%& (,/#(,$0%& ; %0*% 0/!% , !*%0%&.
Co.)6o.( )( t((r-tur- =
-
7/25/2019 Trabajo Final Legislacion Farmaceutica Grupo 301504 2
12/19
LEGISLACION FARMACEUTICA 12
#"(#,$#(/,$0% ,& (; #"0# ; "# ,0/=,0#
*,%(/,$# =, &, ,)# #"(#,$#* ,$ "#*
8*,&%: ," !*%0% !,, #*#*&, ,$ $
*,8*/,*#%*: #&0#$% ," *#$% (,/#$0, $
0,*(%&0#0%.S/$ /$/#/$ S/ $% ,&!,/8/# $# 0,(!,*#0*# ,
#"(#,$#(/,$0% % ,$ "# ,0/=,0# $% #!#*,,
$/$$# , "#& *,%(,$#/%$,& #$0,*/%*,&: "#
0,(!,*#0*# ," "#* ,), (#$0,$,*&, #&0#
$ (>/(% ,
25 C. T,(!,*#0*#& &!,*/%*,& ,0,*/%*#$ "%&
(,/#(,$0%& !,& #"0,*#$ "# ,&0#)/"/# ;:
!%* ,$,: "# #"/# , "%& (/&(%&.
S/ "# 0,(!,*#0*# #()/,$0, ," "#* , #"(#,$#(/,$0% ,& (; #"0# ; "# ,0/=,0#
*,%(/,$# =, &, ,)# #"(#,$#* ,$ "#* 8*,&%: ," !*%0% !,, #*#*&, ,$ $
*,8*/,*#%*: #&0#$% ," *#$% (,/#$0, $ 0,*(%&0#0%.
S/$ /$/#/$ S/ $% ,&!,/8/# $# 0,(!,*#0*# , #"(#,$#(/,$0% % ,$ "# ,0/=,0# $%
#!#*,, $/$$# , "#& *,%(,$#/%$,& #$0,*/%*,&: "# 0,(!,*#0*# ," "#* ,),
(#$0,$,*&, #&0# $ (>/(% , 25 C. T,(!,*#0*#& &!,*/%*,& ,0,*/%*#$ "%&
(,/#(,$0%& !,& #"0,*#$ "# ,&0#)/"/# ;: !%* ,$,: "# #"/# , "%& (/&(%&.
M-.t(.(.to )( 6-)(.- )( >r,o:L%& (,/#(,$0%& =, *,=/,*#$ *,8*/,*#/$
&,*>$ #"(#,$#%& ,$ #*0%& 8*%&: $,6,*#&: *,8*/,*#%*,& % %$,"#%*,&. S, ,),
%$0#* %$ $ !"#$ , ,(,*,$/# =, #*#$0/, ," (#$0,$/(/,$0% , #,$# , 8*%: ,$
#&% , /$0,**!/%$,& , "# ,$,*# ,"90*/#. A//%$#"(,$0,: ,),*> /&!%$,*&, , $0,*((,0*% =, *,/&0*, "# 0,(!,*#0*# ; "",6#* $ *,/&0*% /#*/% 6#*/#& 6,,& #" #. L#
#$0/# , (,/%& , *,8*/,*#/$ &,*> ,0,*(/$## !%* "#& $,,&/#,& ,
#"(#,$#(/,$0%.
;r(- A66(or-'
!-?o:D,),$ ,&0#* )/#%& 8,*# , "#& >*,#& , #"(#,$#(/,$0% ; ,$ #$0/#
&8//,$0,: , #,*% %$ ," $(,*% , %!,*#*/%&: 0,$/,$% ,$ ,$0# "#& $%*(#& =,
!#*# 0#" ,8,0% &, #;#$ ,!,/%.
-
7/25/2019 Trabajo Final Legislacion Farmaceutica Grupo 301504 2
13/19
LEGISLACION FARMACEUTICA 13
V(tu-ro:L#& /$&0#"#/%$,& ,&0/$##& #" #()/% , *%!#& ; & #*#: #& %(% "#& ,
"/(!/,# ; #**,"% !,*&%$#": ,),$ &,* #,&/)",& ; #,##& #" $(,*% , %!,*#*/%&
,),$ )/#*&, , #,*% %$ ," 8"% ," !,*&%$#" ; ,&0#* %0##& %$ #&/"",*%&
/$,!,$/,$0,& !#*# "# *%!# , #"", ; %0#/$ , 0*#)#%.
@o.- )( -ur-:E" ,&0#)",/(/,$0% ,), /&!%$,* , $# %$# !#*# ," ,!&/0% , "#&
)#&*#&: "# #" ,), ,&0#* #/&"## , "#& >*,#& , #"(#,$#(/,$0% ;%
#%$//%$#(/,$0% , /&!%&/0/6%& (9/%&: ,(#*## , /,$0/8/## ; %0## ,
#$,#& !*%0,/#& , /,$0/8/##& , #,*% %$ ," 0/!% , ,&,%.
@o.- )( *--)o )( *((.to )( -(o: E" ,&0#)",/(/,$0% ,), /&!%$,* , >*,#&
&,!#*##& !#*# ," "#6#% , /(!",(,$0%& , #&,%: "#& #",& ,&0#*>$ /&,##& , 0#"
8%*(# =, "%& !*%,&%& =, &, ,**%""#$ ,$ "#& (/&(#& $% ,$,*,$ (,# $/
%$0#(/$#/$ # "#& >*,#& #",##&.
PLANOS
PERSONAL
S#"# , *,,!/$ S#"# S#"#& M9/% C%$&"0%* D%0%*,&E$8,*(,*#&J,8, , ,$"#,E$#*#%& ,%(,$0#/$M,$,*%&
T,"98%$% /$0,*$%I$0,*%($/#%*M,$,*%
-
7/25/2019 Trabajo Final Legislacion Farmaceutica Grupo 301504 2
14/19
LEGISLACION FARMACEUTICA 14
P%*0#%*,& ,(,&0*#&
UTI+/*8#$%& J,8, , +/*8#$%&A$,&0,&/&0#J,8, , ,$8,*(,*#&D%0%*,&E$8,*(,*#&J,8, , ,$"#,R#/*#8%E$#*#%& ,%(,$0#/$M,$,*%&
P%*0#%*,& ,(,&0*#&
T,"98%$% /$0,*$%I$0,*%($/#%*M,$,*%
R#/%"%# R#;%& X
R#/"%%&R#/*#8%&O!,*#%*,&E$#*#%& ,%(,$0#/$
T,"98%$% /$0,*$%
%$# ,%$,$0*#/$: ,
!#/,$0,& #%& ,#"0#
E$8,*(,*#&T*#)##%*#&&%/#",&C#(/"",*%&E$#*#%& ,#*/6%
T,"98%$% /$0,*$%
C,$0*% , C%$0*%" ,
I$8%*(#/$
C%%*/$#%* *#$0,
," ,&0*, ,%!,*#/%$,&J,8, , ,$8,*(,*#A(/$/&0*#%*J,8, , /$8%*(#/$," %&!/0#"E(!",#%& ,%8//$#M,$,*%&
R#/%
L$,#& 8,*# ,"/*,0%*/%T,"98%$% /$0,*$%I$0,*%($/#%*M,$,*%
R,,!/$ , R,,!/$ J,8, , *,,!/$ , T,"98%$% /$0,*$%
-
7/25/2019 Trabajo Final Legislacion Farmaceutica Grupo 301504 2
15/19
LEGISLACION FARMACEUTICA 15
6%"$0#*/%& !*/$/!#" 6%"$0#*/%&J,8, , &,*6//%&/$0,*$%&C#(/"",*%
%$# , ,&!,*# !#*#8#(/"/#*,& , ,*/%&
C%(,%*
T*#)##%*#&&%/#",&C",*%
T,"98%$% /$0,*$%
DOCUMENTACION
L# %(,$0#/$ ,),*> %$0,$,* $# ,"#*#/$ !%"0/#: "%& %),0/6%& ,"&/&0,(# , /$6,$0#*/%&: $ (#$#" , #"/#: "# %(,$0#/$ ; "%& *,/&0*%& ,"
&/&0,(# , /$6,$0#*/%&. S, *,=/,*, ,$ "% !%&/)", &/&0,(#0/#* "# /$8%*(#/$ !#*# "%
#" &, /&!%$*> , "%& &//,$0,& ,",(0%&
Q#*, % &%80#*, F%*(#0%& I$8%*(,& %$0#)",&
DOTACI%N A0*/" !%*0# &,*%& B#"#$#& C#(# %&!/0#"#*/# C#(/""# !#*# ,#(,$ C#(/""# /$,%"/# C#**% !#*# *#/%$,& G*#/""# , 1 ; 2 !#&%& I$8#$0(,0*%
L>(!#*#& , ,""% , /&$, M,& , (#;% V/0*/$#&
EUIPOS 1 #/0#%* - *%0#%* 1 #$#"/#%* ,",0*%"/0%& 1 #0%"#6, 1 )#"#$# #$#"0/# ; "$/# 1 )#"#$# , !*,/&/$ 1 )#% , !#*#8/$#
-
7/25/2019 Trabajo Final Legislacion Farmaceutica Grupo 301504 2
16/19
LEGISLACION FARMACEUTICA 16
1 )#% 0%*),""/$% 1 )%()# #&!/*#/$ 1 #",8#0%* 1 ,$0*8# 2 %"%$%&%!/% 1 %$0#%* ,(#0%"/% ,&8/)*/"#%* 1 ,%#*/%*#8% %!!",* 1,%0%(%*#8% ,",0*%& )/&0* 1 ,",0*%#*/*#8% ,=/!% , &/$ 1 ,=/!% /,&0/6% 2 ,=/!% %$#
1 ,=/!% *#;%& 1 ,&!/*(,0*% 1 ,&0#)/"/#%* , 6%"0 1 ,&08# "0/6% 2 ,&08# , &,#% 1 8/)*%%"%$%&%!/% 1 8*%$0%" 1< 8,$0,& , " /$)#%*#& )/%"/#& 1 /$&*/!0%* ("0/#$#" 1 ">(!#*# =/**/# 1 "#!#*%&%!/# 1 "#&,* 1 (#(%*#8% 2 (#=/$# #$,&0,&/# 1 (#=/$# #&!/*#/$ 1 (,/%* ,*(,0//# (, =/**/# 1 (/*%&%!/%
1 (/*0%(% %$,"#/$ 1 (%$/0%* #$,&0,&/#: #*/#%:%2: ,&8/)*/"#%*: *: &/$%& 2 !#$,$%&%!/% 1 0%(# !*,&/$ //0#"
1 "0*#&%$/%
COSTOS !(.(>6o )( *- 6o.t-*)-) )( 6oto
E" !*%,&% , /(!",(,$0#/$ , "# %$0#)/"/# , %&0%& # "%*#% /6,*&%&
*,&"0#%&: ,$0*% , "%& =, &, ,&0##$ %$0#* %$ $# $/# "#&/8/#/$ , %&0%&!#*# $/#,& , $,%/% ; ,$0*%& , %&0%&: ,$,*#$% , ,&0# (#$,*# 6#"%*,&
-
7/25/2019 Trabajo Final Legislacion Farmaceutica Grupo 301504 2
17/19
LEGISLACION FARMACEUTICA 17
#*,#%& !#*# "# #&/$#/$ , !*,&!,&0%&: /,$0/8/#/$ , "%& %&0%& , $%
#"/#: $,%/#/%$,& %$ !*,&0#%*,& , &,*6//%&: *#/%$#"/#/$ , "%& *,*&%& ;
%!0/(/#/$ , "# 0/"/#/$ , "# #!#/# /$&0#"##: ,$0*, %0*%&.
!u(.o r(u*t-)o (. *- 6o.t-*)-) )( 6oto
T(.(r (. 6u(.t-:
- S/&0,(#& , I$8%*(#/$ /$0,*#%& %$ "%& !*%,&%& (/&/%$#",& ; ,
#!%;%.
- P,*&%$#" %$ #)/"/#,& ; %(!,0,$/#&.
- L/,*#% ,$ "# ,&0/$ ,&0*#09/# !%* ," ,**%""% ; #!*%!/#/$ ,"
0,(# , !#*0, , "#& ,*,$/#& ; "#& $0#& /*,0/6#& , "#& ,(!*,&:
/$%*!%*>$%"% # "# "0*# %*#$/#/%$#".
-
I$%*!%*#/$ , "# ,&0*0*# , "# %$0#)/"/# , "%& %&0%& ,$ "%&&/&0,(#& %(,$0#",& , "#& ,(!*,&: ,$,*#$% "0*#
%*#$/#/%$#" &%)*, ," 0,(#.
- T*#)##* ,$ #/%$,& , (,%*#(/,$0% %$ "#& ,**#(/,$0#& , #"/#
%8*,/#& !%* "# $%*(# NTC-GP 1
-
7/25/2019 Trabajo Final Legislacion Farmaceutica Grupo 301504 2
18/19
LEGISLACION FARMACEUTICA 18
/$//#",&
C%(/09 , F#*(#/#P*,&!,&0%& ;*,*&%&
5 2
-
7/25/2019 Trabajo Final Legislacion Farmaceutica Grupo 301504 2
19/19
LEGISLACION FARMACEUTICA 19
H' REFERENCIAS B#**,0% L$# F*,; E$*/=, 2
top related